SLEEK/COMPACT KODAK EASYSHARE CAMERA LAUNCHED.Eastman Kodak Company (NYSE NYSESee: New York Stock Exchange :EK) has announced the latest M-Series Digital Camera to join its EASYSHARE System portfolio. The KODAK EASYSHARE M1093 IS Digital Camera, a sleek but powerful digital camera for style-conscious consumers, is packed with innovative features, including Kodak's Smart Capture, which instantly adjusts the camera settings to help ensure brilliant pictures in virtually any environment -- automatically. "Underneath its sleek exterior, the KODAK EASYSHARE M1093 IS Digital Camera is a powerhouse built to capture beautiful pictures," said John Blake, general manager Digital Capture and Devices, vice president, Eastman Kodak Company. "The Smart Capture feature available on our latest digital cameras, including the M1093 IS, lets consumers capture moments that would have otherwise been missed, thanks to its intuitive and automatic scene detection and setting control." KODAK EASYSHARE M1093 IS Digital Camera The KODAK EASYSHARE M1093 IS Digital Camera is the newest member of Kodak's line of affordable EASYSHARE M-Series Zoom Digital Cameras for the style-savvy consumer. A range of features lets consumers capture and share their memorable moments quickly and effortlessly: -- Innovative Smart Capture feature identifies the scene and adjusts camera settings for a great picture in just about any environment -- automatically. -- Take stunning HD pictures and video and view them on an HDTV (High Definition TV) A set of digital television (DTV) standards that offer the highest resolution and sharpest picture. Although some HDTV sets are available in standard (rather square) screen sizes, the overwhelming majority of sets are wide screen, which eliminates with the optional KODAK EASYSHARE HDTV Dock. -- Reduce blur caused by camera shake, subject movement or fast-action situations with image stabilization and blur reduction technology. -- For great shots of friends and family, face detection technology locates faces and automatically adjusts the camera settings. -- Capture the details in low light conditions and fast action situations with high ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. (up to 3200). Pricing and Availability The KODAK EASYSHARE M1093 IS Digital Camera will retail for US$199.95 MSRP MSRP Manufacturer's Suggested Retail Price MSRP Message Session Relay Protocol MSRP Multi-Species Recovery Plan (US Fish & Wildlife Service) MSRP Member of the Society for Radiological Protection (UK) from September 2008. About the KODAK EASYSHARE System Kodak continues to bring groundbreaking features to its award-winning KODAK EASYSHARE Digital Photography System, enhancing the digital photography experience for consumers worldwide. The EASYSHARE System consists of digital cameras, picture frames, snapshot printers, online services, software, inkjet printers, and accessories -- making picture taking, sharing and archiving effortless. All KODAK EASYSHARE Products being introduced include the latest Version 7 of KODAK EASYSHARE Software featuring an array of enhancements to help consumers find, create and share pictures like never before. Version 7 Software now includes direct access to KODAK Gallery making it simple to find albums stored online. The new KODAK EASYSHARE Software Version 7 can be downloaded for free. About Eastman Kodak Company As the world's foremost imaging innovator, Kodak helps consumers, businesses, and creative professionals unleash the power of pictures and printing to enrich their lives. For more information, visit http://www.kodak.com or call 585/724-7735. >TX NEW TOOLS IN DEVELOPMENT FOR BREAST CANCER DETECTION >TX Leading breast cancer researchers from across the country convened the first meeting of the Avon Foundation Breast Cancer Prevention Research Initiative. The two-day meeting, brought together researchers from leading institutions who are focused on the remarkable research in breast cancer biomarkers that has taken place over the last three years. The goal was to use the latest biomarker knowledge to develop new tests for the earliest detection and diagnostics in breast cancer --ultimately leading to monitor the earliest changes in healthy breasts before cancer occurs. Current breast cancer screening This article or section recently underwent a major revision or rewrite and needs further review. You can help! X-ray mammography Mammography is still the modality of choice for screening of early breast cancer, since it is relatively fast, reasonably accurate, and relies primarily on imaging, including mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her , ultrasound and MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. . While these diagnostic modalities provide the opportunity for detection and successful treatment, the aim of the new Avon Foundation-funded research initiative is to pursue non-imaging techniques that offer compelling and innovative opportunities. In support of this novel direction, 12 projects were selected through a competitive application process, with a total of $7.6 million awarded in support of their research. The projects, which are focused on fairly simple but effective methods, range from developing a new "band-aid" dipstick dipstick /dip·stick/ (dip´stik) a strip of cellulose chemically impregnated to render it sensitive to protein, glucose, or other substances in the urine. that collects fluid from nipple discharge nipple discharge Breast discharge Breast disease Serous or serosanguinous fluid emanating from a nipple, most common in peri- and post-menopausal ♀, due to various lesions–eg, intraductal papilloma, nipple adenoma, ductal ectasia, Paget's disease of to several projects that attempt to measure markers in blood to detect the very earliest breast cancer development. The leaders of the research projects are meeting to present preliminary findings and share ideas in a spirit of collaboration and a shared commitment to ending breast cancer. Included is one pharmaceutical company, A&G Pharmaceutical, in addition to the individual medical researchers. "The Avon Foundation is proud to support these researchers in their innovative approaches to breast cancer detection and prevention," stated Marc Hurlbert, PhD, Director of the Avon Foundation Breast Cancer Crusade. "Our goal is to advance research that will one day eradicate breast cancer and, at the same time, facilitate collaboration and sharing. This meeting is a part of that critical process." The funded researchers and their research initiatives include: Kim Baltzell, PhD, University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). San Francisco Viruses in breast fluid as possible biomarkers for breast cancer David Gilley, PhD, and Hiromi Tanaka, PhD, Indiana University Telomere telomere /telo·mere/ (tel´o-mer) an extremity of a chromosome, which has specific properties, one of which is a polarity that prevents reunion with any fragment after a chromosome has been broken. dysfunction markers for breast cancer detection Bassem Haddad, MD, Georgetown University Improving the diagnostic power of ductal lavage for early detection of breast cancer by assessing multiple molecular markers in the same specimen Sam Hanash, MD, PhD, Fred Hutchinson Cancer Research Center Validation of an autoantibody autoantibody /au·to·an·ti·body/ (-an´ti-bod?e) an antibody formed in response to, and reacting against, an antigenic constituent of one's own tissues. au·to·an·ti·bod·y n. signature for breast cancer Gary Johanning, PhD, University of Texas M.D. Anderson Cancer Center Breast cancer screening by assessing serum HERV-K antibodies and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic Celina Kleer, MD, University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. Enhancer of Zeste2 as a biomarker of preneoplastic progression in the breast Susan Love, MD, Dr. Susan Love Research Foundation Development of a breast fluid test to identify women at risk for breast cancer Emanuel Petricoin, PhD, George Mason University Named after American revolutionary, patriot and founding father George Mason, the university was founded as a branch of the University of Virginia in 1957 and became an independent institution in 1972. Phosphopeptide biomarkers for early breast cancer detection in women with mammographically occult cancer Ginette Serrero, PhD, A&G Pharmaceutical Development of GP88 serum test for early breast cancer diagnosis Charles Streckfus, DDS (1) (Digital Data Storage) See DAT. (2) (Data Dictionary System) See QuickBuild and OpenDDS. (3) (Dataphone Digital S , MA, FAOM FAOM First Action On Merits FAOM Florida Association of Oriental Medicine, Inc. FAOM Flight Attendant Operations Manual (FAA requirement) , University of Texas Health Sciences Center at Houston Identifying biomarkers for breast cancer detection in saliva Sara Sukumar, PhD, Johns Hopkins / Seema Khan, MD, Northwestern Gene methylation methylation, n a phase-II detoxification pathway in the liver; methyl groups combine with toxins to rid the body of various substances. methylation (meth´ and estradiol levels in random FNA FNA Fine needle aspiration, see there samples as biomarkers of breast cancer risk Thea Tlsty, PhD, University of California San Francisco Molecular markers that predict future formation of malignant breast cancer The Breast Cancer Prevention Research Initiative is one of many programs of the Avon Foundation Breast Cancer Crusade. The Avon Crusade first launched in 1992, and, through 2007, more than $525 million has been raised in over 50 countries worldwide to advance access to care and finding a cure for breast cancer, with a focus on the medically underserved. Funding is awarded to beneficiaries ranging from leading cancer centers to community-based nonprofit organizations for breast cancer outreach and education; screening and diagnostics; access to treatment; support services; and medical research. The Avon Crusade is the largest initiative of the Avon Foundation, a 501(c)(3) public charity with a mission to improve the lives of women, with a focus on breast cancer and domestic violence. For more information, call 917/209-9518 or visit http://www.avonfoundation.org. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion